Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma - PubMed (original) (raw)
. 2012 Jul 20;30(21):2678-83.
doi: 10.1200/JCO.2011.37.8539. Epub 2012 Jun 18.
Affiliations
- PMID: 22711850
- DOI: 10.1200/JCO.2011.37.8539
Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma
Farhad Azimi et al. J Clin Oncol. 2012.
Abstract
Purpose: To determine whether density and distribution of tumor-infiltrating lymphocytes (TILs; TIL grade) is an independent predictor of sentinel lymph node (SLN) status and survival in patients with clinically localized primary cutaneous melanoma.
Methods: From the Melanoma Institute Australia database, 1,865 patients with a single primary melanoma ≥ 0.75 mm in thickness were identified. The associations of clinical and pathologic factors with SLN status, recurrence-free survival (RFS), and melanoma-specific survival (MSS) were analyzed.
Results: The majority of patients had either no (TIL grade 0; 35.4%) or few (TIL grade 1; 45.1%) TILs, with a minority showing moderate (TIL grade 2; 16.3%) or marked (TIL grade 3; 3.2%) TILs. Tumor thickness, mitotic rate, and Clark level were inversely correlated with TIL grade (each P < .001). SLN biopsy was performed in 1,138 patients (61.0%) and was positive in 252 (22.1%). There was a significant inverse association between SLN status and TIL grade (SLN positivity rates for each TIL grade: 0, 27.8%; 1, 20.1%; 2, 18.3%; 3, 5.6%; P < .001). Predictors of SLN positivity were decreasing age (P < .001), decreasing TIL grade (P < .001), ulceration (P = .003), increasing tumor thickness (P = .01), satellitosis (P = .03), and increasing mitoses (P = .03). The 5-year MSS and RFS rates were 83% and 76%, respectively (median follow-up, 43 months). Tumor thickness (P < .001), ulceration (P < .001), satellitosis (P < .001), mitotic rate (P = .003), TIL grade (P < .001), and sex (P = .01) were independent predictors of MSS. Patients with TIL grade 3 tumors had 100% survival.
Conclusion: TIL grade is an independent predictor of survival and SLN status in patients with melanoma. Patients with a pronounced TIL infiltrate have an excellent prognosis.
Similar articles
- Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS. Taylor RC, et al. J Clin Oncol. 2007 Mar 1;25(7):869-75. doi: 10.1200/JCO.2006.08.9755. J Clin Oncol. 2007. PMID: 17327608 - Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
Murali R, Haydu LE, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Thompson JF, Scolyer RA. Murali R, et al. Ann Surg. 2012 Jan;255(1):128-33. doi: 10.1097/SLA.0b013e3182306c72. Ann Surg. 2012. PMID: 21975320 - Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, Marchesi L, Poletti P, Bonomi L, Novellino L, Di Biagio K, Milesi A, Guerra U, Tondini C. Mandalà M, et al. Eur J Cancer. 2009 Sep;45(14):2537-45. doi: 10.1016/j.ejca.2009.05.034. Epub 2009 Jun 22. Eur J Cancer. 2009. PMID: 19553103 - Role of sentinel lymph node biopsy in patients with thin melanoma.
Andtbacka RH, Gershenwald JE. Andtbacka RH, et al. J Natl Compr Canc Netw. 2009 Mar;7(3):308-17. doi: 10.6004/jnccn.2009.0023. J Natl Compr Canc Netw. 2009. PMID: 19401063 Review. - Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate.
Balch CM, Gershenwald JE, Soong SJ, Thompson JF. Balch CM, et al. J Surg Oncol. 2011 Sep;104(4):379-85. doi: 10.1002/jso.21876. J Surg Oncol. 2011. PMID: 21858832 Review.
Cited by
- YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy.
Hu J, Qiu D, Yu A, Hu J, Deng H, Li H, Yi Z, Chen J, Zu X. Hu J, et al. Front Oncol. 2021 May 6;11:607224. doi: 10.3389/fonc.2021.607224. eCollection 2021. Front Oncol. 2021. PMID: 34026603 Free PMC article. - Identification of RUNX1 and IFNGR2 as prognostic-related biomarkers correlated with immune infiltration and subtype differentiation of low-grade glioma.
Zhang X, Chu H, Cheng Y, Ren J, Wang W, Liu X, Yan X. Zhang X, et al. Biomol Biomed. 2023 May 1;23(3):405-425. doi: 10.17305/bjbms.2022.8086. Biomol Biomed. 2023. PMID: 36321611 Free PMC article. - The host STING pathway at the interface of cancer and immunity.
Corrales L, McWhirter SM, Dubensky TW Jr, Gajewski TF. Corrales L, et al. J Clin Invest. 2016 Jul 1;126(7):2404-11. doi: 10.1172/JCI86892. Epub 2016 Jul 1. J Clin Invest. 2016. PMID: 27367184 Free PMC article. Review. - Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer.
Xiao C, Yang L, Jin L, Lin W, Zhang F, Huang S, Huang Z. Xiao C, et al. Front Genet. 2022 Aug 19;13:962028. doi: 10.3389/fgene.2022.962028. eCollection 2022. Front Genet. 2022. PMID: 36061184 Free PMC article. - Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management.
Plunkett KR, Armitage JD, Inderjeeth AJ, McDonnell AM, Waithman J, Lau PKH. Plunkett KR, et al. Front Immunol. 2022 Nov 16;13:1048758. doi: 10.3389/fimmu.2022.1048758. eCollection 2022. Front Immunol. 2022. PMID: 36466880 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical